Having trouble reading this? View it in your browser.
Avadis NGS August 11, 2011
News & Updates

New video on creating bacterial genome annotations from GenBank files

Avadis NGS provides easy access to genomic annotations for commonly investigated organisms like mouse, rat, human, and many more. However, our growing annotations database does not yet include many strains of bacteria. If you are working with bacterial genomes and need to create the annotations in Avadis NGS, then watch our latest video tutorial.

After watching this video tutorial, you will be able to easily create your bacteria's reference genome from a GenBank file with the Avadis NGS Annotations Manager and Script #10 in our online scripts library.

Latest version of Avadis NGS is compatible with Mac OS X Lion

Avadis NGS version 1.2.3 was released on 5 August 2011, making Avadis NGS fully compatible with Apple's new operating system Mac OS X Lion (version 10.7). However, we recommend that all Avadis NGS users upgrade their installations to this new version of Avadis NGS. The complete release notes are available here.

One of the major updates in Mac OS X Lion, affecting Avadis NGS and many other applications, is that Java is no longer bundled with the OS by default. Moreover, upgrading from Snow Leopard to Lion wipes out the presence of Java on your Mac. Java is essential for running all versions of Avadis NGS on a Mac, so if you are a current user of Avadis NGS and would like to continue using versions equal to or earlier than v1.2.2, please follow these instructions when starting Avadis NGS for the first time after upgrading to Mac OS X Lion.

If you are already using Mac OS X Lion and are installing Avadis NGS for the first time, you need to install version 1.2.3 of Avadis NGS. You will not be able to install earlier versions of the software. You can find more information on this here.


Feature Highlight


Our Genome Browser offers a wide range of visualizations

Make optimal use of the Avadis NGS Genome Browser's wide range of visualizations to explore your data.

With Avadis NGS's fully embedded, feature rich, and easy to use Genome Browser, you can:
  • perform comprehensive visualizations
  • bring in your data from external sources and simply drag and drop to view your data
  • enable simultaneous visualizations of your raw sequencing data, analysis results, and public annotations in a single view.
Below: Single window visualization in the genome browser

The simultaneous view of genomic data, algorithm results, and public annotations allows you to identify this peak and correlate it with the adjacent LIN28A gene.


Upcoming Events


Webinar of the Month: Pathway Analysis in Avadis NGS

Find out more about Avadis NGS and how it can benefit your research by attending one of our free webinars. You can register here for the following sessions:

Subject
Date
Pacific Daylight Time
(San Francisco)
Eastern Daylight Time
(New York)
Central European Time
(Berlin)
China Time
(Beijing)
Pathway Analysis
18 August 2011
-- -- 11 AM 5 PM
Pathway Analysis
24 August 2011
10 AM 1 PM -- --


As always, if you can't make it for one of these dates you also have the option to request a private webinar session by selecting "I would prefer a private session for my organization" from the Preferred Date menu on the registration page.


Share your Thoughts!


Let us know what you think about Avadis NGS! If you have ideas for new features, or believe there is something that can be improved in our next release, don't hesitate to tell us about it. At Strand, we do our best to build and support the most useful solutions for your NGS analysis needs.

- The Avadis NGS Team

StrandThis message was sent to you by Strand Scientific Intelligence, Inc. 548 Market Street, Suite 82804, San Francisco, CA 94104, www.strandsi.com. Avadis is a registered trademark of Strand Life Sciences Private Limited. You have received this email because you have opted in to receive messages regarding Avadis NGS. You may click here to unsubscribe if you don't want to receive emails from Strand Scientific Intelligence, Inc.